Show latest about:
Israeli stocks on Wall St
Israeli stocks in Europe
Mergers & acquisitions
Politics, foreign affairs
Start-ups & VC
Israeli stocks in NY
Israel in depth
Mylan shareholders approve Perrigo takeover bid
65% of Mylan's shareholders approved the $30 billion takeover bid for Perrigo.
28 Aug 15 17:37
Macrocure share price plunges after trial failure
The Phase III clinical trial for CureXcell for treatment of venous leg ulcers is not expected to meet its main target.
23 Aug 15 16:03
UBS: Copaxone sales strong despite generic rivals
UBS says, "The launch for generic Copaxone has not gone very well, with molecule share hovering around 5%."
20 Aug 15 15:14
Teva to oppose Mylan's bid to take over Perrigo
Teva has a 4.6% stake in Mylan and has lost $370 million on paper on its holdings in its rival.
18 Aug 15 19:16
MeMed swiftly diagnoses if a disease is viral or bacterial
The Israeli company's innovative diagnostic solutions reduce use of unnecessary antibiotics.
19 Aug 15 16:14
Teva torn between two very different types of drugs
Teva is faced with an identity crisis: generic or branded pharmaceutical company? IBI VP Elah Alkalay discusses the challenges.
5 Aug 15 11:21
Israeli company offers new hope for treating severe depression
NeuroRX, run by brothers Jonathan and Daniel Javitt, is based on research spurred by a close friend's suicide.
1 Jul 15 16:16
For more results from our archive,